VIRAL POLYMERASE INHIBITORS

Jedinjenje odabrano među ili njegova so ili ester.Prijava sadrži još 31 patentni zahtev. An enantiomer, diastereoisomer or tautomer of a compound, represented by formula I: wherein A, B, R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 , and R 10 are as defined herein, or a salt or ester thereof,...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	CHABOT, CATHERINE, TSANTRIZOS, YOULA S, POIRIER, MARTIN, STAMMERS, TIMOTHY A, BEAULIEU, PIERRE, BROCHU, CHRISTIAN, THAVONEKHAM, BOUNKHAM, RANCOURT, JEAN
Format:	Patent
Sprache:	eng ; srp
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Jedinjenje odabrano među ili njegova so ili ester.Prijava sadrži još 31 patentni zahtev. An enantiomer, diastereoisomer or tautomer of a compound, represented by formula I: wherein A, B, R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 , and R 10 are as defined herein, or a salt or ester thereof, as an inhibitor of HCV NS5B polymerase.